Get the Stockscreener App
1.76
2.22%
-0.04
Whitehawk Therapeutics Inc stock is traded at $1.76, with a volume of 2,392.
It is down -2.22% in the last 24 hours and down -11.11% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$1.80
Open:
$1.76
24h Volume:
2,392
Relative Volume:
0.02
Market Cap:
$83.62M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.57%
1M Performance:
-11.11%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.7106
$1.775
1-Week Range:
$1.70
$1.82
52-Week Range:
$1.39
$2.20
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
1.775 | 83.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.34 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.49 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.20 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
671.01 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.05 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Whitehawk Therapeutics earnings missed by $1.01, revenue was in line with estimates - Investing.com Canada
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - PR Newswire
Pattern recognition hints at Whitehawk Therapeutics Inc. upsideMomentum-Based Prediction for Quick Returns - Newser
Full technical analysis of Whitehawk Therapeutics Inc. stockShort-Term Profit Alert With Entry Forecast - Newser
Forecasting Whitehawk Therapeutics Inc. price range with options dataInsider Strategy for High Conviction Picks - Newser
Has Whitehawk Therapeutics Inc. found a price floorFree Technical Stock Breakout Predictions - Newser
Technical analysis overview for Whitehawk Therapeutics Inc. stockFree Daily Chart Pattern Stock Forecast - Newser
Heatmap analysis for Whitehawk Therapeutics Inc. and competitorsTechnical Analysis of Growth Stock Opportunities - Newser
How Whitehawk Therapeutics Inc. stock performs during market volatilityTrade Alert System with Volume Analysis - Newser
What makes Whitehawk Therapeutics Inc. stock price move sharplySwing Trade Watchlist with Entry Zones - Newser
Developing predictive dashboards with Whitehawk Therapeutics Inc. dataShort-Term Price Breakout Signal Analysis - Newser
Using RSI to spot recovery in Whitehawk Therapeutics Inc.Breakout Monitoring with Momentum Analysis - Newser
What MACD and RSI say about Whitehawk Therapeutics Inc.Pattern Breakout Prediction for Short Term - Newser
What are the latest earnings results for Whitehawk Therapeutics Inc.Unlock your trading potential with expert tips - Jammu Links News
How strong is Whitehawk Therapeutics Inc. company’s balance sheetGet alerts on the hottest stocks daily - Jammu Links News
What analysts say about Whitehawk Therapeutics Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Whitehawk Therapeutics Inc. a good long term investmentUnlock exclusive trading strategies for gains - Jammu Links News
What institutional investors are buying Whitehawk Therapeutics Inc. stockUnlock powerful trading signals for profits - Jammu Links News
Price action breakdown for Whitehawk Therapeutics Inc.Long Hold Investment Strategy with Growth Focus - Newser
Backtesting results for Whitehawk Therapeutics Inc. trading strategiesReal-Time Investment Signal Forecast with AI - Newser
Should I hold or sell Whitehawk Therapeutics Inc. stock in 2025Invest smarter with data-backed insights - Jammu Links News
Why is Whitehawk Therapeutics Inc. stock attracting strong analyst attentionDiscover high-impact investment opportunities - Jammu Links News
How does Whitehawk Therapeutics Inc. generate profit in a changing economyAchieve consistent double-digit growth rates - Jammu Links News
Is Whitehawk Therapeutics Inc. a growth stock or a value stockMaximize returns with smart investment plans - Jammu Links News
Is Whitehawk Therapeutics Inc. stock entering bullish territoryFree Daily Picks With Predictable Performance - Newser
Published on: 2025-08-02 04:05:32 - metal.it
What is the risk reward ratio of investing in Whitehawk Therapeutics Inc. stockDaily Trading Updates For Smart Trading - Jammu Links News
Published on: 2025-08-01 19:41:45 - metal.it
Whitehawk Therapeutics Inc expected to post earnings of 49 cents a shareEarnings Preview - TradingView
Whitehawk Therapeutics Inc. Stock Support and Resistance Levels You Should KnowDaily Volume Spike Trading Signals Detected - metal.it
Intraday pattern recognizer results for Whitehawk Therapeutics Inc.Swing Trade Timing with Daily Forecast - Newser
Support Zone Holds Steady for Whitehawk Therapeutics Inc. After DipScalable Portfolio Growth Suggestions Released - metal.it
Whitehawk Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionEarly Entry Picks Before News Breakout Reviewed - metal.it
Whitehawk Therapeutics Inc. Recovery Likely Here’s What Data ShowsMarket Momentum and Signal Alerts Suggest Reversal - metal.it
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.46%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):